Notícias Tonix Pharmaceuticals Holding Corporation - TNXP | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Tonix Pharmaceuticals Holding Corporation (TNXP)
Tonix Pharmaceuticals Holding Corporation (TNXP) Notícias

Tonix Pharmaceuticals Holding Corporation (TNXP)

0,19

-0,0142

(-6,95%)

Fechado 23 Novembro 6:00PM

Atrasado por 15 minutos

0,1848

-0,0052

(-2,74%)

Após o horário de negociação: 9:59PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Form 8-K - Current report

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

Form 8-K - Current report

Form 8-K - Current report

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

Form 8-K - Current report

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Tonix Pharmaceuticals

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições